Marguerite Hogan
Child & Adolescent Psychiatry · San Antonio, TXNPI 1174630867
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 168 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,187 and has fallen 98.6% since, to $17 in 2025.
Across 168 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$624
- Sunovion Pharmaceuticals Inc.$409
- Takeda Pharmaceuticals U.S.A., Inc.$323
- Ironshore Pharmaceuticals Inc.$292
- Otsuka America Pharmaceutical, Inc.$219
- Johnson & Johnson$213
- plus $748 from 13 others
What the payments were for
- Food & beverage$2,79999%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 46 | $624 |
| Sunovion Pharmaceuticals Inc. | 22 | $409 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $323 |
| Ironshore Pharmaceuticals Inc. | 11 | $292 |
| Otsuka America Pharmaceutical, Inc. | 6 | $219 |
| Johnson & Johnson | 12 | $213 |
| Lundbeck LLC | 13 | $206 |
| Vanda Pharmaceuticals Inc. | 13 | $193 |
| Adlon Therapeutics L.p. | 4 | $56 |
| Shire North American Group Inc | 3 | $52 |
| Arbor Pharmaceuticals, Inc. | 4 | $48 |
| Eisai Inc. | 3 | $41 |
| Neos Therapeutics, LP | 3 | $40 |
| Merck | 2 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| Bausch Health US, LLC | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Rhodes Pharmaceuticals L.p. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,829 in reported general payments places this provider in the 85th percentile of 301 child & adolescent psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 16 | $591 |
| Bupropion XlBupropion Hcl | 17 | $499 |
| Lamotrigine | 24 | $330 |
| Quetiapine Fumarate | 12 | $172 |
| Duloxetine Hcl | 16 | $118 |
| Clonazepam | 13 | $97 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in San Antonio
- Steven PliszkaSan Antonio$59K
- Mary Garcia HolguinSan Antonio$24K
- Maria DominguezSan Antonio$7K
- Amber MansoorSan Antonio$6K
- Andrew MartinSan Antonio$6K
- Thomas DemoorSan Antonio$5K
- Vanessa VelaSan Antonio$3K
- Grace Salinas GarciaSan Antonio$2K
- Hector SamaniegoSan Antonio$2K
- Alain KaticBellaire$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.